Kura Oncology, Inc.

NASDAQ:KURA

Biotechnology

Healthcare
$7.35 +0.73%

+$0.07 today

Market cap
$675.31M
Beta
0.36
P/E (TTM)
-2.9
EPS (TTM)
-$3.32
52W Low $5.45High $12.49

Volume 1.66M

Average 1.66M

Balance Sheet

Inspect the capital base behind the business.

Assets

$738.36M

FY 2025 · Annual

-2.9% YoY

Liabilities

$564.23M

FY 2025 · Annual

+62.8% YoY

Equity

$174.13M

FY 2025 · Annual

-57.9% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents90.67M51.8M37.32M224.46M149.1M
Short-term Investments427.29M386.18M386.64M502.93M518.14M
Net Receivables000012.6M
Inventory0000413K
Other Current Assets1.4M8.44M8.52M17.43M28.41M
Total Current Assets522.29M446.43M432.48M744.83M708.66M
Property, Plant & Equipment (Net)8.25M6.38M8.85M7.49M15.16M
Goodwill00000
Intangible Assets00000
Long-term Investments00000
Tax Assets00000
Other Non-current Assets3.52M3.5M7.6M7.85M14.54M
Total Non-current Assets11.76M9.88M16.45M15.33M29.7M
Total Assets534.05M456.31M448.94M760.16M738.36M
Account Payables3.24M1.53M2.3M1.47M5.02M
Short-term Debt0002.61M0
Tax Payables0002.06M0
Deferred Revenue00024.27M48.98M
Other Current Liabilities7.92M10.3M13.15M17.51M22.37M
Total Current Liabilities22.46M24.06M35.26M78.71M116.97M
Long-term Debt09.16M9.33M6.92M9.71M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)000253.91M424.91M
Other Non-current Liabilities375K265K705K1.8M3.16M
Total Non-current Liabilities4.99M11.97M16.4M267.81M447.25M
Total Liabilities27.44M36.03M51.66M346.52M564.23M
Common Stock7K7K7K8K9K
Retained Earnings(432.97M)(568.81M)(721.44M)(895.42M)(1.17B)
Accumulated OCI(1.79M)(8.03M)(1.27M)764K1.02M
Other Stockholders Equity00000
Minority Interest00000
Total Equity506.61M420.28M397.27M413.64M174.14M
Total Debt6.88M14.02M17.2M16.59M20.46M
Net Debt(83.8M)(37.78M)(20.12M)(207.87M)(128.64M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$39.1M
Short-term Investments$541.7M
Receivables$13.6M
Inventory$843.0K
Other Current$28.5M
Total Current Assets$623.8M
PP&E (Net)$14.8M
Other Non-current$14.0M
Total Non-current Assets$28.8M
Total Assets$652.6M

Analysis

Selected assets total $652.6M for Latest. The largest visible component is Short-term Investments at $541.7M, about 83.0% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
S-3ASRS-3ASR filingNov 10, 2026
8-KCurrent reportNov 10, 2026
10-QQuarterly reportNov 10, 2026
SC 13G/ASC 13G/A filingOct 27, 2026
4Statement of changes in beneficial ownershipSep 29, 2026

How much cash does KURA have?

Kura Oncology, Inc. (KURA) reported $149.10M in cash and equivalents in fiscal 2025.

How much debt does KURA carry?

Kura Oncology, Inc. (KURA) reported $20.46M of total debt, with net debt of -$128.64M.